Recently, a clustering of different types of dystonia was reported in the families of patients with musician's dystonia, suggesting also a genetic contribution to the disease. 4 However, the underlying molecular genetic factors are currently unknown. We here investigated in a case-control design whether intensive practice or other environmental factors are associated with musician's dystonia in combination with genetic susceptibility.
Methods | For this report, we compared 110 patients with musician's hand dystonia with 99 healthy professional musicians (similar environment) and 61 healthy first-degree family members of the affected musicians, who, on average, share half of the genetic information with the former (similar genetic background). We studied the time spent on fine motor tasks, such as playing the instrument, writing or typing, and other potential environmental triggers, 2 using structured personal interviews, neurological examination, and questionnaires. 4 The study was approved by the local ethics committee and all subjects gave written informed consent. Details on the recruitment of the study sample and measurements are listed in the Table. Continuous variables were compared using analysis of variance and t tests, and categorical variables using χ 2 tests supplemented with 95%
confidence intervals. All tests were 2-sided, with a significance level of 0.05 and performed using IBM SPSS Statistics version 20 (SPSS Inc).
Results | Characteristics of musicians with dystonia were consistent with earlier reports 2 including predominance of males and soloists and increased frequency of positive fam- ily history compared with healthy musicians (Table) . Before dystonia onset, patients had spent a mean (SD) of 26 329 (14 459) hours on their instruments and 41 834 (18 587) hours on all fine motor tasks combined with the affected Figure) . The average annual practice time before the individual/mean onset of dystonia was comparable between both groups of musicians. Any potential environmental trigger within 6 months before dystonia onset was reported by 35% of the patients. Also, 79% of healthy musicians and 28% of healthy family members reported potential triggers during their lives (Table) .
Discussion | Our results were consistent with a complex etiologic disease model 1,2 combining genetic susceptibility and environmental factors. Suggesting a genetic association, patients with dystonia had been exposed to a similar environment regarding practice time and comprised significantly more familial cases compared with the healthy musicians. In support of an environmental association, affected musicians had spent significantly more hours on all fine motor tasks than their healthy first-degree family members who shared a similar genetic background. Intriguingly, an early age at first practice was correlated with a lower risk for developing musician's dystonia. This finding is in keeping with previous data on the use-dependent increase of related cortical brain representations in musicians, the size of which correlates with age at first practice, possibly reflecting a protective effect. 5 A limitation of our study included the cross-sectional design precluding causal inferences despite biological plausibility. Furthermore, retrospective assessment of triggers may be subject to recall bias; therefore, rather than performing a direct comparison of the trigger frequencies, we documented their presence in all groups. Both limitations could be addressed by prospective study designs, a challenging but feasible task, given that there are a registered 176 200 professional musicians in the United States alone. All fine motor tasks combined P < .001 (2-sided ANOVA)
Bars indicate means and 95% confidence intervals. ANOVA indicates analysis of variance; HFM, healthy family member (of patients with musician's dystonia); HM, healthy musician; MHD, musician's hand dystonia.
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Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids and Fatal B-Cell Lymphoma
To the Editor De Graaff and colleagues 1 described a 57-year-old male patient who initially presented with clinical, radiologic, and pathologic features of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) and had an unfavorable outcome. This is an interesting case because it remains an enigma whether CLIPPERS is an isolated disease or a syndrome including different overlapping diseases and their prestages. In this article, as indicated in the title and the abstract, brain biopsy was performed for a confirmed diagnosis of lymphomatoid granulomatosis that evolved into fatal B-cell lymphoma of the central nervous system. However, this was not specified in the text. We wonder how B-cell lymphoma was diagnosed? As mentioned by the authors, the second brain biopsy revealed numerous large atypical B lymphocytes positive for Epstein-Barr virus-encoded RNA, which is pathognomonic for lymphomatoid granulomatosis, and diffuse large B-cell lymphoma. 1 Further investigation, such as immunohistochemistry, should be important for the differentiation between lymphomatoid granulomatosis and diffuse large B-cell lymphoma. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids is a recently described inflammatory disease in the central nervous system with a characteristic brain pattern of symmetric curvilinear gadolinium enhancement peppering the pons and extending variably into the medulla, brachium pontis, cerebellum, midbrain, and occasionally spinal cord.
2 Although
Pittock and colleagues 2 suggested that typical clinical and magnetic resonance imaging features of CLIPPERS could be treated without pathologic examination after rigorously excluding differential diagnoses, the diagnostic challenge in differentiating CLIPPERS from primary central nervous system lymphoma has been proposed by other researchers. 3 Limousin and colleagues 3 reported a similar case of CLIP-PERS that became steroid resistant and was finally diagnosed as type B primary central nervous system lymphoma. In that case, magnetic resonance spectroscopy features (a high Cho/NAA ratio and high in-phase resonance of free lipids) observed in an early phase suggested the final diagnosis. 3 The usefulness of magnetic resonance spectroscopy has been described in the diagnosis of primary central nervous system lymphoma, 4 and thus appears promising in the differential diagnosis of CLIPPERS as well. In summary, primary central nervous system lymphoma is an important differential diagnosis of CLIPPERS and thus should be suspected, especially when the patients become resistant to steroids during a later phase.
In Reply With interest we read the letter to the editor by Zhang and Wu. As described, our patient presented with recurrent episodes of neurologic deficit, improving after administration of steroids compatible with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. 1 Eventually, the patient was diagnosed as having lymphomatoid granulomatosis resulting in a B-cell lymphoma. This central nervous system B-cell lymphoma was suggested by magnetic resonance imaging characteristics and biopsy prior to the patient's death and was confirmed by postmortem autopsy. Microscopic tissue analysis showed a large pontine area (markedly enhancing on brain magnetic resonance imaging) with necrosis and a focal thalamus lesion with large atypical lymphocytes and perivascular infiltrates, including atypical lymphocytes, small lymphocytes, and macrophages, compatible with a B-cell lymphoma. Immunohistochemistry findings indicated large quantities of atypical CD-20-positive cells with some T cells. About 10% to 20% of tumor cells were Epstein-Barr virus-encoded RNA positive. Thus, the final diagnosis of B-cell lymphoma could be confirmed post mortem. We agree that magnetic resonance spec-
